MEDVi vs Ro vs PlexusDx for cash-pay GLP-1 weight loss: real annualized cost math, compounded vs FDA-approved branded, safety considerations, and where genetic baselining changes the dose decision before week one.

MEDVi, Remedy Meds, and PlexusDx all dispense compounded semaglutide and tirzepatide — but the annualized cost, billing cadence, and clinical-oversight model differ in ways the landing pages don't show. This guide walks the real numbers, the September 2025 FDA warning-letter context, and where PlexusDx Weight Management Protocols ($129–$325/mo) plus the Precision Peptide Genetic Test fit relative to both.

MEDVi vs Lilly Direct vs PlexusDx in 2026: all-inclusive compounded telehealth, FDA-approved Zepbound at self-pay vial pricing, and a genetics-anchored compounded protocol. Real 12-month math, the 45-day refill trap, and where each fits.

MEDVi vs Hims vs PlexusDx in 2026: MEDVi at $179 first month then $299/mo with no contract, Hims at $199/mo gated behind a $1,194 six-month prepayment, and PlexusDx Weight Management Protocols from $129/mo with no upfront commitment and an optional Precision Peptide Genetic Test for genetic-guided GLP-1 dosing.

MEDVi vs Hers vs PlexusDx in 2026: real annual cost math, compounded vs FDA-approved branded medication source, tirzepatide availability across all three, cancellation and refund policy differences, and where the Precision Peptide Genetic Test fits when GLP-1 response varies by GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants.

MEDVi vs Gala GLP-1 vs PlexusDx compared on verified 2026 pricing, compounded vs FDA-approved status, cancellation rules, and where a genetic baseline changes the dose decision before week one.

MEDVi semaglutide ranges from $149 to $299/month depending on which page you land on. We reconcile every published MEDVi rate against PlexusDx Semaglutide Injection ($179-$229/mo) and Semaglutide Oral (from $209/mo) on a 12-month total-cost basis — with the genetic baseline MEDVi doesn’t offer.

MEDVi sells two different oral GLP-1 products under one banner: a compounded semaglutide tablet from $249/month and a Wegovy pill route at $99/month membership plus medication. We unpack the pricing, the FDA regulatory status, the 72-hour cancellation rule, and where PlexusDx Semaglutide Oral ($209/mo+) and Microdose GLP-1 Protocol ($129/mo flat) fit for cash-pay readers who want a non-injection GLP-1.

Is SHED legit? Yes — verified LLC, named pharmacy partners, 875+ reviews — but with a 2-month minimum and 72-hour cancellation cutoff. Compare SHED to PlexusDx Weight Management Protocols: month-to-month, no membership, with optional Precision Peptide Genetic Test before titration.

Is GLP-1 HRA, FSA, or HSA eligible? Often yes when prescribed for a diagnosed condition, but the rules vary by plan. Here is the framework, the documentation you need, and where PlexusDx Weight Management Protocols (from $129/mo, all 50 states, no membership) fit when your account does not cover GLP-1s for weight loss.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.

Constipation is one of the most common GLP-1 side effects — here's the food, fluid, movement, and dose-adjustment playbook that actually works, plus where the PlexusDx Microdose GLP-1 Protocol and Precision Peptide Genetic Test fit in.

A GLP-1 program under $300/month is real in 2026 if you pick a structure that doesn't reset in month two. Four PlexusDx protocols stay under the cap at every published dose tier: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $179–$229/mo, Tirzepatide Injection from $229/mo, and GLP-Squared from $179/mo — all cash-pay, all-inclusive, no membership.

Eight GLP-1 programs publish verified outcome-based money-back guarantees as of April 2026 — Eden, SHED, Brightmeds, Fella Health, RemedyMeds, Calibrate, Aayu Well, and LifeMD — each with 6–12 month windows and structured adherence requirements. PlexusDx does not offer an outcome guarantee but prices flat with no membership and no required commitment, so risk is bounded by one month of cost rather than by a 6–12 month adherence schedule.

What's common, what's serious, and how to manage GLP-1 side effects from FDA-labeled known information — including the boxed warning that applies to both semaglutide and tirzepatide, when to call your provider, and how PlexusDx structures titration and the optional Precision Peptide Genetic Test.

The honest list of GLP-1 options under $200/mo in April 2026 is much shorter than the ads suggest. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest under-$200 option in this comparison, with PlexusDx Semaglutide Injection at $179/mo entry tier as the lowest weekly compounded semaglutide path. FDA-approved Foundayo and the Wegovy pill start at $149/mo at lower doses but escalate with dose; most other “$199 GLP-1” ads are first-month-only promos that jump to $249–$349 on refill.

Wellness stipends typically reimburse GLP-1 programs through receipt upload, not direct employer billing. PlexusDx accepts payment from cards issued under wellness stipend and LSA programs (Compt, Forma, Espresa, Fringe, Benepass, PeopleKeep) and provides itemized receipts — but does not bill employers directly. Stipend eligibility depends on your employer's plan language, especially around “FDA-approved” vs “prescription medication” phrasing for compounded GLP-1s.

Pennsylvania Medicaid cut GLP-1 coverage for adult weight loss on January 1, 2026. This guide walks the legal cash-pay telehealth options that ship to PA, the compounded vs FDA-approved branded distinction, real annualized costs, and where PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($179–$229/mo), and Tirzepatide Injection ($229–$309/mo) sit relative to Eden, Ro, TrimRx, Willow, and MEDVi — with the optional Precision Peptide Genetic Test anchoring dose decisions to your DNA before week one.

Ohio's GLP-1 coverage fractured in 2025-2026 — State of Ohio employee plan, OSU Health Plan, and Ohio Medicaid all narrowed weight-loss GLP-1 access. This guide walks the cash-pay landscape, Ohio telehealth law, compounded vs FDA-approved options, and where PlexusDx Weight Management Protocols ($129/mo flat to $309/mo) fit for Ohio residents.

NH Medicaid dropped GLP-1 weight-loss coverage on January 1, 2026. Here’s the cash-pay landscape for New Hampshire residents in 2026 — telehealth eligibility, real prices from $129 to $1,349/mo, compounded vs FDA-approved trade-offs, and where PlexusDx Weight Management Protocols fit.

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth. Kentucky Medicaid does not cover GLP-1 for weight loss. PlexusDx Weight Management Protocols ship to all 120 Kentucky counties from $129/mo flat with no membership fee.

The full 2026 GLP-1 cost map: Wegovy, Ozempic, Zepbound, and Mounjaro at branded list price; Lilly Direct and NovoCare manufacturer self-pay programs ($149–$499/mo); cash-pay compounded telehealth alternatives. PlexusDx Weight Management Protocols span $129–$509/mo with all-inclusive pricing, no membership, all 50 states.

Foundayo's $149 headline is a one-month starter price — the real cash-pay year runs $3,338–$3,738 once you escalate. Compare PlexusDx Microdose GLP-1 ($129/mo flat), Semaglutide Oral ($209+/mo), and Tirzepatide Oral ($229+/mo) on annualized cost.

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149–$349/month self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $179–$229/mo, Tirzepatide Injection $229–$309/mo — with no membership fee.

Eden semaglutide reviews reveal flat-dose pricing strengths, BBB complaint friction, and four published price points across Eden's own pages. Compare Eden's compounded semaglutide with PlexusDx Semaglutide Injection ($179–$229/mo), Microdose GLP-1 ($129/mo flat), and Semaglutide Oral (from $209/mo) — cash-pay, no membership, with optional genetic-test dose personalization.

Eden vs Ro vs PlexusDx for cash-pay GLP-1 weight loss in 2026: real annualized cost math on Eden’s $129–$329/mo all-inclusive compounded plans, Ro’s $149/mo membership plus FDA-approved branded medication (Wegovy, Zepbound, Ozempic, Foundayo), and PlexusDx Weight Management Protocols from $129/mo — with the Precision Peptide Genetic Test as a $99 add-on so dosing is anchored to GLP1R, GIPR, FTO, MC4R, and TCF7L2 variants before week one.

Eden cancellation policy explained: $0 fee, no contract, but refunds hinge on the pharmacy cutoff. Step-by-step portal and email cancellation, prepaid 3-month plan rules, medical-reason refund path, and how PlexusDx month-to-month protocols ($129–$509/mo, no membership, all 50 states) sidestep the cutoff problem.

MEDVi’s compounded plans bundle medication and platform into one price (no separate membership fee); branded Wegovy/Zepbound paths add a $99/mo membership. We reconcile MEDVi’s fee structure, the 28-day billing cycle, and where PlexusDx Weight Management Protocols sit at $129–$325/mo with no membership fee on any tier.

Compare the best online tirzepatide providers in 2026 — Ro, Eden, Yucca Health, Willow, Sesame — against the PlexusDx Tirzepatide Injection ($229–$309/mo) and Tirzepatide Oral ($229–$509/mo) Protocols, with a genetic baseline option no other provider offers.

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $179–$229/mo.